AdaptHealth (AHCO) – Research Analysts’ Recent Ratings Changes

AdaptHealth (NASDAQ: AHCO) has recently received a number of price target changes and ratings updates:

• 5/11/2026 – AdaptHealth had its price target raised by Royal Bank Of Canada from $13.00 to $15.00. They now have an “outperform” rating on the stock.
• 5/9/2026 – AdaptHealth was upgraded by Wall Street Zen from “hold” to “buy”.
• 5/6/2026 – AdaptHealth had its price target raised by Canaccord Genuity Group Inc. from $14.00 to $16.00. They now have a “buy” rating on the stock.
• 5/6/2026 – AdaptHealth was given a new $18.00 price target by Robert W. Baird.
• 5/6/2026 – AdaptHealth had its price target lowered by UBS Group AG from $15.00 to $14.00. They now have a “buy” rating on the stock.
• 4/20/2026 – AdaptHealth had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $11.00 price target on the stock.
• 4/13/2026 – AdaptHealth had its price target raised by Truist Financial Corporation from $13.00 to $14.00. They now have a “buy” rating on the stock.

Insiders Place Their Bets

In related news, major shareholder Richard M. Cashin, Jr. acquired 820,528 shares of the stock in a transaction that occurred on Tuesday, March 10th. The shares were bought at an average price of $9.73 per share, for a total transaction of $7,983,737.44. Following the completion of the transaction, the insider directly owned 14,638,708 shares in the company, valued at approximately $142,434,628.84. This trade represents a 5.94% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have purchased a total of 2,494,518 shares of company stock worth $24,352,291 in the last 90 days. 1.95% of the stock is owned by corporate insiders.

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.